We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
Read MoreHide Full Article
In the latest trading session, HCA Healthcare (HCA - Free Report) closed at $279.33, marking a -0.77% move from the previous day. This change lagged the S&P 500's 0.15% loss on the day. On the other hand, the Dow registered a loss of 0.42%, and the technology-centric Nasdaq increased by 0.09%.
The the stock of hospital operator has risen by 7.43% in the past month, leading the Medical sector's gain of 6.58% and the S&P 500's gain of 3.5%.
The upcoming earnings release of HCA Healthcare will be of great interest to investors. The company's earnings report is expected on January 30, 2024. The company is expected to report EPS of $5.02, up 8.19% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $16.55 billion, up 6.77% from the year-ago period.
It is also important to note the recent changes to analyst estimates for HCA Healthcare. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.24% higher within the past month. HCA Healthcare is currently a Zacks Rank #3 (Hold).
In terms of valuation, HCA Healthcare is presently being traded at a Forward P/E ratio of 14.42. This denotes no noticeable deviation relative to the industry's average Forward P/E of 14.42.
Meanwhile, HCA's PEG ratio is currently 1.51. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Hospital was holding an average PEG ratio of 1.67 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 31, placing it within the top 13% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow HCA in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
In the latest trading session, HCA Healthcare (HCA - Free Report) closed at $279.33, marking a -0.77% move from the previous day. This change lagged the S&P 500's 0.15% loss on the day. On the other hand, the Dow registered a loss of 0.42%, and the technology-centric Nasdaq increased by 0.09%.
The the stock of hospital operator has risen by 7.43% in the past month, leading the Medical sector's gain of 6.58% and the S&P 500's gain of 3.5%.
The upcoming earnings release of HCA Healthcare will be of great interest to investors. The company's earnings report is expected on January 30, 2024. The company is expected to report EPS of $5.02, up 8.19% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $16.55 billion, up 6.77% from the year-ago period.
It is also important to note the recent changes to analyst estimates for HCA Healthcare. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.24% higher within the past month. HCA Healthcare is currently a Zacks Rank #3 (Hold).
In terms of valuation, HCA Healthcare is presently being traded at a Forward P/E ratio of 14.42. This denotes no noticeable deviation relative to the industry's average Forward P/E of 14.42.
Meanwhile, HCA's PEG ratio is currently 1.51. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Hospital was holding an average PEG ratio of 1.67 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 31, placing it within the top 13% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow HCA in the coming trading sessions, be sure to utilize Zacks.com.